Evaluating the Medical Advisor / Medical Science Liaison (MSL) Function: Key Performance Indicators Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Evaluating the Medical Advisor / Medical Science Liaison (MSL) Function: Key Performance Indicators (Executive Summary)" report to their offering.

This executive summary outlines results from the full study which rethinks how the Medical Advisor - Medical Science Liaison (MSL) role is evaluated. It presents findings and assessment of current practices from feedback from 37 executives across 26 organizations from 11 countries. The analysis provides executives with the key performance indicators and metrics, models of MSL performance assessments based on products' lifecycles, as well as a consensus model.

Upper Level Management, MSL Managers and MSLs have struggled with establishing appropriate practices to evaluate a MSL's work. We find the issue mainly lies in the nature of the MSL function, a function that evolves with a product, from early phases to maturity. Whereas the set of activities of a MSL stays fairly the same throughout, they are applied to various degrees based on where the supported products are in their lifecycle.

So then, how best should the evaluation of the MSL role be handled? Should it follow one single path, with similar focus across time or should the evaluation follow distinct criteria based on what needs to be done in each phase of the product lifecycle? These are questions that the majority of MSL Managers face year after year, with no real answers.

While we believe there should be somewhat of an overhaul to the traditional model, we conducted this study to identify most common trends and perceptions amongst medical affairs executives surveyed through the research. And in the process, provide a performance assessment model that encompasses all findings.

Key Topics Covered:

1. Methodology

2. Respondents' Profiles

- Working Environments

- Profiled Companies

3. Changes in MSL Cohort Size

- Status of Team Deployment

- Future Expectations

4. Key Metrics: Medical Advisors Activities

- Typical Activities - Pre-launch

- Typical Activities - Post-launch

- MSLs' Involvement in Product Lifecycle

- Key MSL/KOL Relationship Metrics

- Number of Thought Leader Relationships

- Frequency of Interactions

- Length of In-Person Visits

- MSL Time Dedication to Type of Product

5. Evaluation Patterns and Criteria

- Frequency of Reviews

- Preferred Flow Patterns of MSLs' Performance Evaluations

- The One-Phase Approach

- The Two-Phase Approach

- The Three-Phase Approach

- The Four-Phase Approach

- Assessment of Selected Evaluation Criteria

- Factors Influencing KOL Relationships

- A Consensus Roadmap Model for MSL Performance Reviews

6. Additional Information

For more information about this report visit http://www.researchandmarkets.com/research/qcrlds/evaluating_the

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Management

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Management